Pipeline

Updated as of December 2024.

Discover our ongoing cell therapy development pipeline, which demonstrates our commitment to leading innovations in CAR-T therapy. Within our project pipeline, you will find a wide array of promising cell therapy approaches meticulously crafted and rigorously tested to tackle unmet challenges in the realm of immunotherapy.

Our Pipeline

Project	Modalities	Diseases	Discovery	Preclinical	IND	Phase I	Phase II	Phase III
ECAR01	EndureCAR-T	CRC, HCC
ECAR02	EndureCAR-T	Sarcoma, HNCC
ECAR03	EndureCAR-T	Solid Tumor

From initial target validation through preclinical studies, and looking ahead to forthcoming clinical trials, every project within our pipeline embodies our dedication to delivering revolutionary CAR-T therapy development services. Partner with us to drive project advancement in the pipeline or leverage our technology platform and innovative solutions to propel your project forward, jointly shaping the future of cellular immunotherapy.

If you are intrigued by our project pipeline and technology platform, please don't hesitate to contact us for further details.

GET IN TOUCH

Let’s Discuss About Your Project

* Your Name

* Phone Number

* E-mail Address

* Services Interested

Project Description

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and therapeutic services for individuals.